CervoMed Inc. Capital Expenditures
CervoMed Inc. (CRVO) reported Capital Expenditures of $447.82 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2019-03-19.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2019-03-19
- CervoMed Inc. payments to acquire property, plant, and equipment for the quarter ending 2017-12-31 was $9.22K.
- CervoMed Inc. payments to acquire property, plant, and equipment for the quarter ending 2017-09-30 was $374.60K.
- CervoMed Inc. payments to acquire property, plant, and equipment for the quarter ending 2017-06-30 was $57.63K, a 17000.89% increase year-over-year.
- CervoMed Inc. payments to acquire property, plant, and equipment for the quarter ending 2017-03-31 was $6.37K, a 219.56% increase year-over-year.
- CervoMed Inc. payments to acquire property, plant, and equipment for fiscal 2017 was $447.82K, a 19111.63% increase from fiscal 2016.
- CervoMed Inc. payments to acquire property, plant, and equipment for fiscal 2016 was $2.33K, a 94.21% decline from fiscal 2015.
- CervoMed Inc. payments to acquire property, plant, and equipment for fiscal 2015 was $40.29K, a 20.86% decline from fiscal 2014.
- CervoMed Inc. payments to acquire property, plant, and equipment for fiscal 2014 was $50.91K.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 3 month as first filed | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 6 month as first filed | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 9 month as first filed | Payments to Acquire Property, Plant, and Equipment 12 month | Payments to Acquire Property, Plant, and Equipment 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2017-12-31 | $9.22K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-19 | $383.82K derived: sum of 2 quarters · filed 2019-03-19 | $441.45K derived: sum of 3 quarters · filed 2019-03-19 | $447.82K 10-K · filed 2019-03-19 | ||||
| 2017-09-30 | $374.60K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $432.23K derived: sum of 2 quarters · filed 2018-11-13 | $438.60K 10-Q · filed 2018-11-13 | $438.60K derived: sum of 4 quarters · filed 2018-11-13 | ||||
| 2017-06-30 | $57.63K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-10 | $64.00K 10-Q · filed 2018-08-10 | $64.00K derived: sum of 3 quarters · filed 2018-08-10 | $64.00K derived: sum of 4 quarters · filed 2018-08-10 | ||||
| 2017-03-31 | $6.37K 10-Q · filed 2018-05-10 | $6.37K derived: sum of 2 quarters · filed 2018-05-10 | $6.37K derived: sum of 3 quarters · filed 2018-05-10 | $6.71K derived: sum of 4 quarters · filed 2018-05-10 | ||||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $0.00 derived: sum of 2 quarters · filed 2018-04-02 | $337.00 derived: sum of 3 quarters · filed 2018-04-02 | $2.33K 10-K · filed 2018-04-02 | ||||
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | $337.00 derived: sum of 2 quarters · filed 2017-11-13 | $2.33K 10-Q · filed 2017-11-13 | $28.98K derived: sum of 4 quarters · filed 2017-11-13 | ||||
| 2016-06-30 | $337.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $2.33K 10-Q · filed 2017-08-14 | $28.98K derived: sum of 3 quarters · filed 2017-08-14 | $31.68K derived: sum of 4 quarters · filed 2017-08-14 | ||||
| 2016-03-31 | $1.99K 10-Q · filed 2017-05-15 | $28.64K derived: sum of 2 quarters · filed 2017-05-15 | $31.34K derived: sum of 3 quarters · filed 2017-05-15 | $40.10K derived: sum of 4 quarters · filed 2017-05-15 | ||||
| 2015-12-31 | $26.65K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | $29.35K derived: sum of 2 quarters · filed 2017-03-31 | $38.11K derived: sum of 3 quarters · filed 2017-03-31 | $40.29K 10-K · filed 2017-03-31 | $28.23K 10-K · filed 2016-03-25 | |||
| 2015-09-30 | $2.70K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $11.46K derived: sum of 2 quarters · filed 2016-11-14 | $13.64K 10-Q · filed 2016-11-14 | $28.23K 10-Q · filed 2015-11-12 | ||||
| 2015-06-30 | $8.76K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | $10.94K 10-Q · filed 2016-08-15 | $28.23K 10-Q · filed 2015-08-12 | |||||
| 2015-03-31 | $2.18K 10-Q · filed 2016-05-16 | $19.23K 10-Q · filed 2015-05-11 | ||||||
| 2014-12-31 | $50.91K 10-K · filed 2016-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |